Trial Profile
Efficacy of Mogamulizumab in patients with acute and lymphoma type adult T cell leukemia/lymphoma: a single center, retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2017
Price :
$35
*
At a glance
- Drugs Mogamulizumab (Primary)
- Indications Adult T-cell leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 26 Dec 2017 New trial record
- 12 Dec 2017 Results assessing efficacy, presented at the 59th Annual Meeting and Exposition of the American Society of Hematology.